Supply of chronic Mechanical Circulatory Support (MCS)
University Medical Center Groningen (UMCG) announces that for the period from 1 January 2025 to 31 December 2027 (with a possible extension until 31 December 2028), it intends to award a single-source, negotiated contract to Abbott Medical Nederland bv for the supply of chronic Mechanical Circulatory Support (MCS) devices, specifically the Left Ventricular Assist Device (Heartmate™ 3). The procedure is based on an exception to the obligation to tender (Article 2.32 paragraph 1 sub b2 AW) because no reasonable alternative or substitute is available. This announcement serves to inform the market in advance and to provide stakeholders with the opportunity to lodge an objection within 20 calendar days. If no objection is submitted, the right to challenge the procedure expires.
Supplies · Onderhandeling zonder bekendmaking · European procedure
01What is being requested
University Medical Center Groningen (UMCG) announces that for the period from 1 January 2025 to 31 December 2027 (with a possible extension until 31 December 2028), it intends to award a single-source, negotiated contract to Abbott Medical Nederland bv for the supply of chronic Mechanical Circulatory Support (MCS) devices, specifically the Left Ventricular Assist Device (Heartmate™ 3). The procedure is based on an exception to the obligation to tender (Article 2.32 paragraph 1 sub b2 AW) because no reasonable alternative or substitute is available. This announcement serves to inform the market in advance and to provide stakeholders with the opportunity to lodge an objection within 20 calendar days. If no objection is submitted, the right to challenge the procedure expires.
This concerns the announcement in the case of voluntary prior transparency of the intention to award the contract to Abbott Medical Nederland bv for the supply of chronic Mechanical Circulatory Support (MCS) in the form of the Left Ventricular Assist Device (Heartmate™ 3) from 01-01-2025 up to and including 31-12-2027, with the possibility of an extension of 1 year (up to and including 31-12-2028). Based on an exception to the obligation to tender, the contract may be awarded via a single-source negotiated procedure, and UMCG relies on Article 2.32 paragraph 1 sub b2 AW for this purpose. Compe
02Exclusion grounds
- No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).
03Value in context
The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.
04Likely competitors
05Legal themes that may be relevant here
06Frequently asked questions
What is the intended duration of the supply of the MCS equipment?
Which specific medical equipment does the contract concern?
How can stakeholders object to the intended procedure?
What is the reason for the chosen procedure without competition?
Automatically compiled from the official tender data and documents.
07Estimated value versus the market
€ 317K
€ 892K
€ 3,3 mln
Gegunde waarden in CPV 33 · leveringen n=528